Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland Psychedelics Investing
Seelos Therapeutics Announces its Inclusion in the First Psychedelic Exchange Traded Fund Psychedelics Investing
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock Psychedelics Investing
Hollister Biosciences Inc. Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it's 100% owned subsidiary is a category leader with over 4 million grams sold throughout the state in 2020 Psychedelics Investing
Champignon Brands' Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression Psychedelics Investing
